

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA methylation involved in gamete generation (GO:0043046) | 8.38137472 |
| 2 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 8.01728888 |
| 3 | lipopolysaccharide biosynthetic process (GO:0009103) | 7.69058255 |
| 4 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 7.36338592 |
| 5 | regulation of meiosis I (GO:0060631) | 7.08439841 |
| 6 | sulfate transmembrane transport (GO:1902358) | 6.70194796 |
| 7 | lipopolysaccharide metabolic process (GO:0008653) | 6.64189909 |
| 8 | regulation of pigment cell differentiation (GO:0050932) | 6.64176838 |
| 9 | positive regulation of developmental pigmentation (GO:0048087) | 6.56160686 |
| 10 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 6.39028497 |
| 11 | cellular glucuronidation (GO:0052695) | 6.35939042 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.33745820 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 6.33745820 |
| 14 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 6.22309530 |
| 15 | interleukin-6-mediated signaling pathway (GO:0070102) | 6.20497292 |
| 16 | regulation of protein glycosylation (GO:0060049) | 6.10265628 |
| 17 | piRNA metabolic process (GO:0034587) | 6.10011966 |
| 18 | negative regulation of JUN kinase activity (GO:0043508) | 6.03050231 |
| 19 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.89742072 |
| 20 | paraxial mesoderm development (GO:0048339) | 5.87668459 |
| 21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.86719981 |
| 22 | glucuronate metabolic process (GO:0019585) | 5.76628939 |
| 23 | uronic acid metabolic process (GO:0006063) | 5.76628939 |
| 24 | tyrosine metabolic process (GO:0006570) | 5.74336030 |
| 25 | sulfate transport (GO:0008272) | 5.72044948 |
| 26 | centriole replication (GO:0007099) | 5.54577881 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 5.50341213 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.50341213 |
| 29 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.44938138 |
| 30 | notochord development (GO:0030903) | 5.26909621 |
| 31 | negative regulation of chemokine production (GO:0032682) | 5.23329806 |
| 32 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.23133490 |
| 33 | GTP biosynthetic process (GO:0006183) | 5.22453344 |
| 34 | CTP metabolic process (GO:0046036) | 5.08325696 |
| 35 | CTP biosynthetic process (GO:0006241) | 5.08325696 |
| 36 | regulation of interleukin-5 production (GO:0032674) | 4.98278943 |
| 37 | heme transport (GO:0015886) | 4.92062319 |
| 38 | branching involved in salivary gland morphogenesis (GO:0060445) | 4.85368963 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 4.75107648 |
| 40 | regulation of transmission of nerve impulse (GO:0051969) | 4.71159179 |
| 41 | drinking behavior (GO:0042756) | 4.70273290 |
| 42 | monocyte chemotaxis (GO:0002548) | 4.67624070 |
| 43 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 4.63181822 |
| 44 | response to nitrosative stress (GO:0051409) | 4.60146824 |
| 45 | UTP biosynthetic process (GO:0006228) | 4.59609185 |
| 46 | aromatic amino acid family catabolic process (GO:0009074) | 4.57616079 |
| 47 | positive regulation of neurological system process (GO:0031646) | 4.57213083 |
| 48 | response to peptidoglycan (GO:0032494) | 4.56235102 |
| 49 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.51530661 |
| 50 | T cell lineage commitment (GO:0002360) | 4.46750692 |
| 51 | SMAD protein complex assembly (GO:0007183) | 4.46515498 |
| 52 | response to interferon-beta (GO:0035456) | 4.36310425 |
| 53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.35624990 |
| 54 | thrombin receptor signaling pathway (GO:0070493) | 4.34714977 |
| 55 | guanosine-containing compound biosynthetic process (GO:1901070) | 4.31732682 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.28926178 |
| 57 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 4.25152001 |
| 58 | nucleotide transmembrane transport (GO:1901679) | 4.22052720 |
| 59 | positive regulation of meiosis (GO:0045836) | 4.11918006 |
| 60 | UTP metabolic process (GO:0046051) | 4.09200476 |
| 61 | neutrophil mediated immunity (GO:0002446) | 4.04509107 |
| 62 | negative regulation of gluconeogenesis (GO:0045721) | 4.02860597 |
| 63 | glycerol metabolic process (GO:0006071) | 4.01586637 |
| 64 | negative regulation of stem cell proliferation (GO:2000647) | 3.98913046 |
| 65 | hematopoietic stem cell proliferation (GO:0071425) | 3.95822142 |
| 66 | centriole assembly (GO:0098534) | 3.94015871 |
| 67 | ribonucleoprotein complex disassembly (GO:0032988) | 3.93129364 |
| 68 | myotube differentiation (GO:0014902) | 3.92549688 |
| 69 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.92229191 |
| 70 | tachykinin receptor signaling pathway (GO:0007217) | 3.89893242 |
| 71 | meiotic chromosome segregation (GO:0045132) | 3.89525318 |
| 72 | flavonoid metabolic process (GO:0009812) | 3.88319985 |
| 73 | nephron tubule formation (GO:0072079) | 3.85762389 |
| 74 | negative regulation of lipid storage (GO:0010888) | 3.84196015 |
| 75 | aromatic amino acid family metabolic process (GO:0009072) | 3.83658550 |
| 76 | bone remodeling (GO:0046849) | 3.83282449 |
| 77 | positive regulation of meiotic cell cycle (GO:0051446) | 3.81022936 |
| 78 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.80999667 |
| 79 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.80824934 |
| 80 | response to mercury ion (GO:0046689) | 3.77238111 |
| 81 | natural killer cell activation involved in immune response (GO:0002323) | 3.76467452 |
| 82 | left/right axis specification (GO:0070986) | 3.76456424 |
| 83 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.75184286 |
| 84 | nodal signaling pathway (GO:0038092) | 3.74514226 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 3.73729160 |
| 86 | serotonin receptor signaling pathway (GO:0007210) | 3.66216408 |
| 87 | vitamin transmembrane transport (GO:0035461) | 3.64978035 |
| 88 | positive regulation of respiratory burst (GO:0060267) | 3.64094725 |
| 89 | negative regulation of JNK cascade (GO:0046329) | 3.63415280 |
| 90 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.63372905 |
| 91 | alditol metabolic process (GO:0019400) | 3.59700042 |
| 92 | regulation of chemokine biosynthetic process (GO:0045073) | 3.54539518 |
| 93 | pantothenate metabolic process (GO:0015939) | 3.53507994 |
| 94 | NAD biosynthetic process (GO:0009435) | 3.50884950 |
| 95 | iron coordination entity transport (GO:1901678) | 3.45572406 |
| 96 | rhodopsin mediated signaling pathway (GO:0016056) | 3.45203740 |
| 97 | viral mRNA export from host cell nucleus (GO:0046784) | 3.44269089 |
| 98 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.42125427 |
| 99 | iron ion import (GO:0097286) | 3.42034301 |
| 100 | regulation of odontogenesis (GO:0042481) | 3.39718238 |
| 101 | response to epinephrine (GO:0071871) | 3.39670216 |
| 102 | cellular response to gamma radiation (GO:0071480) | 3.39261839 |
| 103 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.37890086 |
| 104 | sulfur compound transport (GO:0072348) | 3.37302575 |
| 105 | spermatid development (GO:0007286) | 3.36597250 |
| 106 | response to caffeine (GO:0031000) | 3.36283960 |
| 107 | neuron maturation (GO:0042551) | 3.35190403 |
| 108 | regulation of developmental pigmentation (GO:0048070) | 3.32287505 |
| 109 | dopamine biosynthetic process (GO:0042416) | 3.32172104 |
| 110 | DNA damage induced protein phosphorylation (GO:0006975) | 3.29178594 |
| 111 | germinal center formation (GO:0002467) | 3.27910057 |
| 112 | somite rostral/caudal axis specification (GO:0032525) | 3.27625219 |
| 113 | indolalkylamine metabolic process (GO:0006586) | 3.27479676 |
| 114 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.26686763 |
| 115 | aspartate family amino acid catabolic process (GO:0009068) | 3.25689589 |
| 116 | regulation of cell fate specification (GO:0042659) | 3.23755720 |
| 117 | nephron tubule development (GO:0072080) | 3.23385077 |
| 118 | nephron epithelium development (GO:0072009) | 3.23314536 |
| 119 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.22634759 |
| 120 | heart valve formation (GO:0003188) | 3.21985038 |
| 121 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.17894557 |
| 122 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.17229597 |
| 123 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.17229597 |
| 124 | negative regulation of stress-activated MAPK cascade (GO:0032873) | 3.16100631 |
| 125 | negative regulation of stress-activated protein kinase signaling cascade (GO:0070303) | 3.16100631 |
| 126 | regulation of triglyceride catabolic process (GO:0010896) | 3.14857915 |
| 127 | response to insecticide (GO:0017085) | 3.14713825 |
| 128 | sperm motility (GO:0030317) | 3.14126260 |
| 129 | cell wall macromolecule catabolic process (GO:0016998) | 3.13335582 |
| 130 | cell wall macromolecule metabolic process (GO:0044036) | 3.13335582 |
| 131 | protein retention in ER lumen (GO:0006621) | 3.12040975 |
| 132 | urate metabolic process (GO:0046415) | 3.07342429 |
| 133 | phospholipid scrambling (GO:0017121) | 3.07185131 |
| 134 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.06611165 |
| 135 | positive regulation of action potential (GO:0045760) | 3.04683945 |
| 136 | phosphate ion transmembrane transport (GO:0035435) | 3.02824910 |
| 137 | cellular response to interferon-beta (GO:0035458) | 3.01679241 |
| 138 | positive regulation of fatty acid oxidation (GO:0046321) | 3.01260335 |
| 139 | tryptophan catabolic process (GO:0006569) | 3.01056309 |
| 140 | indole-containing compound catabolic process (GO:0042436) | 3.01056309 |
| 141 | indolalkylamine catabolic process (GO:0046218) | 3.01056309 |
| 142 | myeloid leukocyte mediated immunity (GO:0002444) | 3.00893761 |
| 143 | post-anal tail morphogenesis (GO:0036342) | 3.00047730 |
| 144 | mitochondrial fission (GO:0000266) | 2.98802404 |
| 145 | sympathetic nervous system development (GO:0048485) | 2.97998987 |
| 146 | toxin transport (GO:1901998) | 2.96122188 |
| 147 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.96109320 |
| 148 | regulation of synapse structural plasticity (GO:0051823) | 2.95753360 |
| 149 | regulation of immunoglobulin secretion (GO:0051023) | 2.92578374 |
| 150 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.92330420 |
| 151 | positive regulation of digestive system process (GO:0060456) | 2.91214095 |
| 152 | regulation of DNA damage checkpoint (GO:2000001) | 2.90839424 |
| 153 | pseudouridine synthesis (GO:0001522) | 2.90614595 |
| 154 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.89815018 |
| 155 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.89815018 |
| 156 | toxin metabolic process (GO:0009404) | 2.89303044 |
| 157 | regulation of synapse maturation (GO:0090128) | 2.88887706 |
| 158 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 2.87573555 |
| 159 | negative regulation of epidermis development (GO:0045683) | 2.86957841 |
| 160 | dopaminergic neuron differentiation (GO:0071542) | 2.86647368 |
| 161 | lysine metabolic process (GO:0006553) | 2.86291362 |
| 162 | lysine catabolic process (GO:0006554) | 2.86291362 |
| 163 | inflammatory response to antigenic stimulus (GO:0002437) | 2.84447021 |
| 164 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 2.84296501 |
| 165 | organelle disassembly (GO:1903008) | 2.82812454 |
| 166 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.82287244 |
| 167 | maturation of SSU-rRNA (GO:0030490) | 2.82003237 |
| 168 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.81352024 |
| 169 | regulation of phospholipase A2 activity (GO:0032429) | 2.80806308 |
| 170 | regulation of sister chromatid cohesion (GO:0007063) | 2.80025524 |
| 171 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.79944401 |
| 172 | negative regulation of metanephros development (GO:0072217) | 2.78772237 |
| 173 | defense response to protozoan (GO:0042832) | 2.77324003 |
| 174 | regulation of keratinocyte proliferation (GO:0010837) | 2.75691842 |
| 175 | renal tubule development (GO:0061326) | 2.75209907 |
| 176 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75095139 |
| 177 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.75081497 |
| 178 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.74109944 |
| 179 | drug transmembrane transport (GO:0006855) | 2.74027087 |
| 180 | cellular ketone body metabolic process (GO:0046950) | 2.72665093 |
| 181 | biotin metabolic process (GO:0006768) | 2.72201675 |
| 182 | neuron fate determination (GO:0048664) | 2.71325848 |
| 183 | aldehyde catabolic process (GO:0046185) | 2.70606036 |
| 184 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.69802511 |
| 185 | regulation of pseudopodium assembly (GO:0031272) | 2.69539700 |
| 186 | acrosome reaction (GO:0007340) | 2.68853394 |
| 187 | organ induction (GO:0001759) | 2.68632831 |
| 188 | histamine transport (GO:0051608) | 2.68586544 |
| 189 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.67400663 |
| 190 | uterus development (GO:0060065) | 2.65746341 |
| 191 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.64999948 |
| 192 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.64964424 |
| 193 | kynurenine metabolic process (GO:0070189) | 2.59329308 |
| 194 | DNA alkylation (GO:0006305) | 2.58985364 |
| 195 | sphingosine metabolic process (GO:0006670) | 14.9782772 |
| 196 | diol metabolic process (GO:0034311) | 13.5641072 |
| 197 | sphingoid metabolic process (GO:0046519) | 12.6442010 |
| 198 | DNA damage response, detection of DNA damage (GO:0042769) | 12.4403619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75635941 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.57118370 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 4.55950301 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.18002851 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.95621132 |
| 6 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.94281162 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.87694545 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.84287796 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.80895969 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.51371533 |
| 11 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.42500191 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36946044 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.35940350 |
| 14 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.22450088 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.13251640 |
| 16 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.05846261 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.7441130 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99545185 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98225704 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93995482 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.91476509 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90806550 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90451806 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90451806 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.82676557 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.80862441 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77741968 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76918249 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76832580 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76300201 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70148737 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.66358915 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65979615 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65745592 |
| 35 | AR_25329375_ChIP-Seq_VCAP_Human | 1.65141146 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64927675 |
| 37 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.61973815 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61293586 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.61281556 |
| 40 | TCF4_23295773_ChIP-Seq_U87_Human | 1.61213389 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60595667 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58663035 |
| 43 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.56199739 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.56194979 |
| 45 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.54716979 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.53324477 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.46879002 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46739872 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.41650063 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41570357 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39618023 |
| 52 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.38631784 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38498951 |
| 54 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38106077 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37704808 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37704808 |
| 57 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37580874 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36403583 |
| 59 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.34861862 |
| 60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.34809493 |
| 61 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.34373137 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32626467 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30129502 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30129502 |
| 65 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.30096740 |
| 66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.28758212 |
| 67 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.28758212 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.27192445 |
| 69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.25319548 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25092580 |
| 71 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24142262 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23969330 |
| 73 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.23161327 |
| 74 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23062366 |
| 75 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22436237 |
| 76 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.21804733 |
| 77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21618484 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21081238 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.20480279 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19681588 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19564381 |
| 82 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.19485128 |
| 83 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19451541 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.18612397 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17798254 |
| 86 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17099159 |
| 87 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.16211717 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15760829 |
| 89 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.15279953 |
| 90 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15167002 |
| 91 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14728906 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14616432 |
| 93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.14091201 |
| 94 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.14015138 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13804500 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13660311 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13120877 |
| 98 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.12750924 |
| 99 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.12307143 |
| 100 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.11814127 |
| 101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10790538 |
| 102 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10542452 |
| 103 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.10406705 |
| 104 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10347624 |
| 105 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09032425 |
| 106 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.08433130 |
| 107 | * AR_19668381_ChIP-Seq_PC3_Human | 1.08169834 |
| 108 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.07864655 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07349300 |
| 110 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.07152754 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06818964 |
| 112 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.06389647 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05295549 |
| 114 | CBP_21632823_ChIP-Seq_H3396_Human | 1.05169713 |
| 115 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05043095 |
| 116 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04501128 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02970651 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02948792 |
| 119 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.00575588 |
| 120 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.00346488 |
| 121 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00085446 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00075089 |
| 123 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00073986 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.99950356 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99607356 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99560529 |
| 127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99208304 |
| 128 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99117820 |
| 129 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98561434 |
| 130 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98361631 |
| 131 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95962968 |
| 132 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95085951 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94791511 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94572165 |
| 135 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94183002 |
| 136 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93527900 |
| 137 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93250513 |
| 138 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93073673 |
| 139 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92330143 |
| 140 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90662331 |
| 141 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90633455 |
| 142 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86599409 |
| 143 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86517297 |
| 144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85337955 |
| 145 | FUS_26573619_Chip-Seq_HEK293_Human | 0.84947075 |
| 146 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83741798 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82939099 |
| 148 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82235510 |
| 149 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.81625385 |
| 150 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81511735 |
| 151 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81511735 |
| 152 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81231761 |
| 153 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81231761 |
| 154 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81136496 |
| 155 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80615339 |
| 156 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80488051 |
| 157 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.79531392 |
| 158 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.78616520 |
| 159 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.78563543 |
| 160 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78505524 |
| 161 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.77023538 |
| 162 | * SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.75051205 |
| 163 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74779419 |
| 164 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.74730269 |
| 165 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.74023664 |
| 166 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73486575 |
| 167 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73242373 |
| 168 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72081707 |
| 169 | EWS_26573619_Chip-Seq_HEK293_Human | 0.71608015 |
| 170 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.71087356 |
| 171 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.70945623 |
| 172 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70639300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 8.88539068 |
| 2 | MP0003136_yellow_coat_color | 7.38259171 |
| 3 | MP0005171_absent_coat_pigmentation | 7.14730010 |
| 4 | MP0009379_abnormal_foot_pigmentation | 6.74296389 |
| 5 | MP0002653_abnormal_ependyma_morphology | 5.29086337 |
| 6 | MP0002009_preneoplasia | 4.67212755 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 4.53256414 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 4.48834925 |
| 9 | MP0003045_fibrosis | 4.39502372 |
| 10 | MP0005083_abnormal_biliary_tract | 4.31657835 |
| 11 | MP0003646_muscle_fatigue | 4.22521017 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 3.97794834 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 3.89595888 |
| 14 | MP0010030_abnormal_orbit_morphology | 3.56053517 |
| 15 | MP0003879_abnormal_hair_cell | 3.51224442 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 3.30126243 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 3.19987826 |
| 18 | MP0005670_abnormal_white_adipose | 2.89118419 |
| 19 | MP0002928_abnormal_bile_duct | 2.85004937 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.83945124 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.72792379 |
| 22 | MP0008057_abnormal_DNA_replication | 2.69978404 |
| 23 | MP0006082_CNS_inflammation | 2.59333200 |
| 24 | MP0004134_abnormal_chest_morphology | 2.52035953 |
| 25 | MP0000749_muscle_degeneration | 2.43980464 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.33265657 |
| 27 | MP0005365_abnormal_bile_salt | 2.26534761 |
| 28 | MP0003195_calcinosis | 2.22936605 |
| 29 | MP0000733_abnormal_muscle_development | 2.14136268 |
| 30 | MP0005410_abnormal_fertilization | 2.11649503 |
| 31 | MP0002168_other_aberrant_phenotype | 1.89761394 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.84444149 |
| 33 | MP0002938_white_spotting | 1.82544771 |
| 34 | MP0000462_abnormal_digestive_system | 1.82229553 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.81753755 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.80227471 |
| 37 | MP0003878_abnormal_ear_physiology | 1.68606804 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.68606804 |
| 39 | MP0000613_abnormal_salivary_gland | 1.67326822 |
| 40 | MP0002006_tumorigenesis | 1.64649113 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.64357157 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.62175632 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.60694704 |
| 44 | MP0003252_abnormal_bile_duct | 1.58057638 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.57040875 |
| 46 | MP0003690_abnormal_glial_cell | 1.54593753 |
| 47 | MP0004147_increased_porphyrin_level | 1.50402499 |
| 48 | MP0000762_abnormal_tongue_morphology | 1.43138149 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.41915089 |
| 50 | MP0006054_spinal_hemorrhage | 1.39389512 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.37359713 |
| 52 | MP0001188_hyperpigmentation | 1.37187162 |
| 53 | MP0010368_abnormal_lymphatic_system | 1.29636699 |
| 54 | MP0003943_abnormal_hepatobiliary_system | 1.28696147 |
| 55 | MP0005395_other_phenotype | 1.28681031 |
| 56 | MP0005409_darkened_coat_color | 1.28471289 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.28267524 |
| 58 | MP0004233_abnormal_muscle_weight | 1.26165173 |
| 59 | MP0001849_ear_inflammation | 1.21179939 |
| 60 | MP0004272_abnormal_basement_membrane | 1.20237839 |
| 61 | MP0003137_abnormal_impulse_conducting | 1.19862461 |
| 62 | MP0009278_abnormal_bone_marrow | 1.18947439 |
| 63 | MP0002075_abnormal_coat/hair_pigmentati | 1.18536621 |
| 64 | MP0005164_abnormal_response_to | 1.18425455 |
| 65 | MP0005166_decreased_susceptibility_to | 1.16571172 |
| 66 | MP0005623_abnormal_meninges_morphology | 1.15864475 |
| 67 | MP0002254_reproductive_system_inflammat | 1.14167792 |
| 68 | MP0001270_distended_abdomen | 1.13800918 |
| 69 | MP0000858_altered_metastatic_potential | 1.13310903 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.12688509 |
| 71 | MP0000678_abnormal_parathyroid_gland | 1.11835158 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.10385293 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.08529475 |
| 74 | MP0004510_myositis | 1.08521871 |
| 75 | MP0005330_cardiomyopathy | 1.05617960 |
| 76 | MP0001764_abnormal_homeostasis | 1.05544003 |
| 77 | MP0001905_abnormal_dopamine_level | 1.05516032 |
| 78 | MP0000049_abnormal_middle_ear | 1.04742590 |
| 79 | MP0001177_atelectasis | 1.03599806 |
| 80 | MP0003283_abnormal_digestive_organ | 1.00904803 |
| 81 | MP0001346_abnormal_lacrimal_gland | 1.00336275 |
| 82 | MP0003786_premature_aging | 0.99789112 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.98868001 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.96742231 |
| 85 | MP0003938_abnormal_ear_development | 0.96565721 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.96186666 |
| 87 | MP0000427_abnormal_hair_cycle | 0.94886252 |
| 88 | MP0004859_abnormal_synaptic_plasticity | 0.94671988 |
| 89 | MP0003941_abnormal_skin_development | 0.92943675 |
| 90 | MP0004484_altered_response_of | 0.92938259 |
| 91 | MP0003011_delayed_dark_adaptation | 0.92822127 |
| 92 | MP0005360_urolithiasis | 0.91659036 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.89853883 |
| 94 | MP0001486_abnormal_startle_reflex | 0.88993502 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.86914504 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.86914504 |
| 97 | MP0002269_muscular_atrophy | 0.86218972 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.85999688 |
| 99 | MP0004381_abnormal_hair_follicle | 0.85328049 |
| 100 | MP0002160_abnormal_reproductive_system | 0.82772399 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.82070301 |
| 102 | MP0001984_abnormal_olfaction | 0.81725814 |
| 103 | MP0008569_lethality_at_weaning | 0.81219104 |
| 104 | MP0004043_abnormal_pH_regulation | 0.80047744 |
| 105 | MP0005408_hypopigmentation | 0.79231132 |
| 106 | MP0004742_abnormal_vestibular_system | 0.77911905 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77011811 |
| 108 | MP0001186_pigmentation_phenotype | 0.75184383 |
| 109 | MP0005451_abnormal_body_composition | 0.74122128 |
| 110 | MP0002272_abnormal_nervous_system | 0.73813505 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.73731540 |
| 112 | MP0002132_abnormal_respiratory_system | 0.72731284 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.72091412 |
| 114 | MP0000566_synostosis | 0.71949631 |
| 115 | MP0009115_abnormal_fat_cell | 0.71907750 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.70713585 |
| 117 | MP0005266_abnormal_metabolism | 0.70466968 |
| 118 | MP0003186_abnormal_redox_activity | 0.70370187 |
| 119 | MP0000579_abnormal_nail_morphology | 0.69023175 |
| 120 | MP0009785_altered_susceptibility_to | 0.68701639 |
| 121 | MP0003787_abnormal_imprinting | 0.68152139 |
| 122 | MP0003698_abnormal_male_reproductive | 0.67049144 |
| 123 | MP0009046_muscle_twitch | 0.66604736 |
| 124 | MP0001324_abnormal_eye_pigmentation | 0.66476795 |
| 125 | MP0008770_decreased_survivor_rate | 0.66449853 |
| 126 | MP0004883_abnormal_blood_vessel | 0.65389530 |
| 127 | MP0000490_abnormal_crypts_of | 0.64459982 |
| 128 | MP0001963_abnormal_hearing_physiology | 0.64402177 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.63232413 |
| 130 | MP0003279_aneurysm | 0.63109689 |
| 131 | MP0009745_abnormal_behavioral_response | 0.62534829 |
| 132 | MP0000372_irregular_coat_pigmentation | 0.61706039 |
| 133 | MP0000163_abnormal_cartilage_morphology | 0.61136041 |
| 134 | MP0009250_abnormal_appendicular_skeleto | 0.60626300 |
| 135 | MP0002971_abnormal_brown_adipose | 0.60122045 |
| 136 | MP0002229_neurodegeneration | 0.59618148 |
| 137 | MP0000026_abnormal_inner_ear | 0.55422390 |
| 138 | MP0001986_abnormal_taste_sensitivity | 0.53252390 |
| 139 | MP0002876_abnormal_thyroid_physiology | 0.52986510 |
| 140 | MP0001968_abnormal_touch/_nociception | 0.51942490 |
| 141 | MP0003724_increased_susceptibility_to | 0.51689961 |
| 142 | MP0003385_abnormal_body_wall | 0.51573305 |
| 143 | MP0001970_abnormal_pain_threshold | 0.51277065 |
| 144 | MP0003315_abnormal_perineum_morphology | 0.51059544 |
| 145 | MP0002736_abnormal_nociception_after | 0.50923736 |
| 146 | MP0002092_abnormal_eye_morphology | 0.49905060 |
| 147 | MP0005646_abnormal_pituitary_gland | 0.48643399 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.48603794 |
| 149 | MP0001929_abnormal_gametogenesis | 0.48065088 |
| 150 | MP0010352_gastrointestinal_tract_polyps | 0.47968629 |
| 151 | MP0004130_abnormal_muscle_cell | 0.47564504 |
| 152 | MP0001485_abnormal_pinna_reflex | 0.47260576 |
| 153 | MP0002396_abnormal_hematopoietic_system | 0.46642011 |
| 154 | MP0009764_decreased_sensitivity_to | 0.46474385 |
| 155 | MP0002064_seizures | 0.45732959 |
| 156 | MP0005253_abnormal_eye_physiology | 0.44798041 |
| 157 | MP0003718_maternal_effect | 0.43611481 |
| 158 | MP0002733_abnormal_thermal_nociception | 0.42843883 |
| 159 | MP0001661_extended_life_span | 0.41115100 |
| 160 | MP0010329_abnormal_lipoprotein_level | 0.38741793 |
| 161 | MP0002572_abnormal_emotion/affect_behav | 0.38492878 |
| 162 | MP0004142_abnormal_muscle_tone | 0.38440744 |
| 163 | MP0008872_abnormal_physiological_respon | 0.37972994 |
| 164 | MP0002118_abnormal_lipid_homeostasis | 0.37868761 |
| 165 | MP0000230_abnormal_systemic_arterial | 0.36607236 |
| 166 | MP0008874_decreased_physiological_sensi | 0.35941383 |
| 167 | MP0002161_abnormal_fertility/fecundity | 0.35005924 |
| 168 | MP0005620_abnormal_muscle_contractility | 0.34142276 |
| 169 | MP0000371_diluted_coat_color | 0.32713470 |
| 170 | MP0005332_abnormal_amino_acid | 0.29654264 |
| 171 | MP0003937_abnormal_limbs/digits/tail_de | 0.29530865 |
| 172 | MP0002210_abnormal_sex_determination | 0.29144278 |
| 173 | MP0005535_abnormal_body_temperature | 0.27790891 |
| 174 | MP0006276_abnormal_autonomic_nervous | 0.26613783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amelogenesis imperfecta (HP:0000705) | 9.07042275 |
| 2 | Focal motor seizures (HP:0011153) | 8.71912582 |
| 3 | Acanthocytosis (HP:0001927) | 7.01846281 |
| 4 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 6.76838521 |
| 5 | Parakeratosis (HP:0001036) | 6.65838057 |
| 6 | Abnormal pancreas size (HP:0012094) | 6.62995225 |
| 7 | Urethral obstruction (HP:0000796) | 5.82334250 |
| 8 | Dialeptic seizures (HP:0011146) | 5.39854382 |
| 9 | Hypoplasia of the uterus (HP:0000013) | 4.65353890 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.59133715 |
| 11 | Ulnar claw (HP:0001178) | 4.54717131 |
| 12 | Axonal loss (HP:0003447) | 4.54084673 |
| 13 | Aplastic anemia (HP:0001915) | 4.52123117 |
| 14 | Abnormal tarsal ossification (HP:0008369) | 4.49483286 |
| 15 | Unilateral renal agenesis (HP:0000122) | 4.31116612 |
| 16 | Focal seizures (HP:0007359) | 4.24360014 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 4.19630123 |
| 18 | Hydroureter (HP:0000072) | 4.03124877 |
| 19 | Proximal tubulopathy (HP:0000114) | 3.93578365 |
| 20 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.87800784 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.86635772 |
| 22 | Severe visual impairment (HP:0001141) | 3.83813952 |
| 23 | Pancreatic cysts (HP:0001737) | 3.81376407 |
| 24 | Facial shape deformation (HP:0011334) | 3.73669724 |
| 25 | Potter facies (HP:0002009) | 3.73669724 |
| 26 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.71832640 |
| 27 | Proximal amyotrophy (HP:0007126) | 3.64607786 |
| 28 | Colon cancer (HP:0003003) | 3.62858292 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.61172050 |
| 30 | Abnormal foot bone ossification (HP:0010675) | 3.59270309 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.56564761 |
| 32 | Difficulty walking (HP:0002355) | 3.54722501 |
| 33 | Pendular nystagmus (HP:0012043) | 3.54639309 |
| 34 | Rectal prolapse (HP:0002035) | 3.54052689 |
| 35 | Abnormality of macular pigmentation (HP:0008002) | 3.53704111 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44297099 |
| 37 | Hematochezia (HP:0002573) | 3.35735183 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 3.34686583 |
| 39 | Erythroderma (HP:0001019) | 3.32765840 |
| 40 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.27464350 |
| 41 | Chorioretinal atrophy (HP:0000533) | 3.23133644 |
| 42 | Opisthotonus (HP:0002179) | 3.21643792 |
| 43 | Upper limb muscle weakness (HP:0003484) | 3.19007996 |
| 44 | Bicornuate uterus (HP:0000813) | 3.18432379 |
| 45 | Abnormality of the hepatic vasculature (HP:0006707) | 3.18281885 |
| 46 | Poikilocytosis (HP:0004447) | 3.12421955 |
| 47 | Gout (HP:0001997) | 3.10741537 |
| 48 | Congenital, generalized hypertrichosis (HP:0004540) | 3.02299537 |
| 49 | Abnormality of the renal cortex (HP:0011035) | 3.01219929 |
| 50 | Renal cortical cysts (HP:0000803) | 2.99987472 |
| 51 | Thrombocytosis (HP:0001894) | 2.99301797 |
| 52 | Esophageal varix (HP:0002040) | 2.99091318 |
| 53 | Scapular winging (HP:0003691) | 2.96565412 |
| 54 | Action tremor (HP:0002345) | 2.92195461 |
| 55 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.90244751 |
| 56 | Abnormality of the vocal cords (HP:0008777) | 2.89423541 |
| 57 | Portal hypertension (HP:0001409) | 2.88388341 |
| 58 | Submucous cleft hard palate (HP:0000176) | 2.87612725 |
| 59 | Broad ribs (HP:0000885) | 2.87471985 |
| 60 | Glucose intolerance (HP:0000833) | 2.85545544 |
| 61 | Enlarged kidneys (HP:0000105) | 2.81388911 |
| 62 | Glycosuria (HP:0003076) | 2.80174849 |
| 63 | Abnormality of urine glucose concentration (HP:0011016) | 2.80174849 |
| 64 | Exocrine pancreatic insufficiency (HP:0001738) | 2.77687386 |
| 65 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.74062421 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.74062421 |
| 67 | Absence seizures (HP:0002121) | 2.70474343 |
| 68 | Hypergonadotropic hypogonadism (HP:0000815) | 2.69094917 |
| 69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.66853555 |
| 70 | Cupped ribs (HP:0000887) | 2.66349284 |
| 71 | Toxemia of pregnancy (HP:0100603) | 2.62014775 |
| 72 | Prostate neoplasm (HP:0100787) | 2.56331865 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53103864 |
| 74 | Overlapping toe (HP:0001845) | 2.52535257 |
| 75 | Conjunctival telangiectasia (HP:0000524) | 2.52518876 |
| 76 | Methylmalonic acidemia (HP:0002912) | 2.50316259 |
| 77 | Prolonged neonatal jaundice (HP:0006579) | 2.50275861 |
| 78 | Renal dysplasia (HP:0000110) | 2.49875722 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 2.49330337 |
| 80 | Down-sloping shoulders (HP:0200021) | 2.48012331 |
| 81 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.47393002 |
| 82 | Aplasia of the phalanges of the hand (HP:0009802) | 2.47393002 |
| 83 | Aplasia involving bones of the extremities (HP:0009825) | 2.47393002 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.47118980 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.44365066 |
| 86 | Shawl scrotum (HP:0000049) | 2.43805270 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.41392866 |
| 88 | Renal Fanconi syndrome (HP:0001994) | 2.40835161 |
| 89 | Stillbirth (HP:0003826) | 2.40649180 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 2.38386557 |
| 91 | Genetic anticipation (HP:0003743) | 2.37898152 |
| 92 | Type I transferrin isoform profile (HP:0003642) | 2.37012986 |
| 93 | 11 pairs of ribs (HP:0000878) | 2.36521021 |
| 94 | Mutism (HP:0002300) | 2.32320744 |
| 95 | Gangrene (HP:0100758) | 2.31964627 |
| 96 | Generalized amyotrophy (HP:0003700) | 2.30673598 |
| 97 | Premature rupture of membranes (HP:0001788) | 2.29879309 |
| 98 | Reticulocytopenia (HP:0001896) | 2.28851770 |
| 99 | Hyperuricemia (HP:0002149) | 2.28282727 |
| 100 | Increased purine levels (HP:0004368) | 2.28282727 |
| 101 | Progressive cerebellar ataxia (HP:0002073) | 2.28156465 |
| 102 | Ureteral stenosis (HP:0000071) | 2.27929543 |
| 103 | Abnormality of carpal bone ossification (HP:0006257) | 2.26510183 |
| 104 | Distal lower limb muscle weakness (HP:0009053) | 2.25079315 |
| 105 | Synostosis of carpal bones (HP:0005048) | 2.22532566 |
| 106 | Atonic seizures (HP:0010819) | 2.22494171 |
| 107 | Annular pancreas (HP:0001734) | 2.21062844 |
| 108 | Hypoplastic iliac wings (HP:0002866) | 2.20508621 |
| 109 | Lipid accumulation in hepatocytes (HP:0006561) | 2.20305871 |
| 110 | Basal ganglia calcification (HP:0002135) | 2.19839977 |
| 111 | Ulnar bowing (HP:0003031) | 2.19770350 |
| 112 | Cerebellar dysplasia (HP:0007033) | 2.19769498 |
| 113 | Chronic diarrhea (HP:0002028) | 2.18710279 |
| 114 | Sprengel anomaly (HP:0000912) | 2.16897835 |
| 115 | Abnormality of potassium homeostasis (HP:0011042) | 2.16599273 |
| 116 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.15730973 |
| 117 | Hyperkalemia (HP:0002153) | 2.15556214 |
| 118 | Severe Myopia (HP:0011003) | 2.15353485 |
| 119 | Nausea (HP:0002018) | 2.15314027 |
| 120 | Hypoalphalipoproteinemia (HP:0003233) | 2.14503497 |
| 121 | Retinitis pigmentosa (HP:0000510) | 2.14047004 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 2.13288365 |
| 123 | Tarsal synostosis (HP:0008368) | 2.11855810 |
| 124 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11639286 |
| 125 | Preauricular pit (HP:0004467) | 2.11002217 |
| 126 | Periauricular skin pits (HP:0100277) | 2.11002217 |
| 127 | Hypokalemia (HP:0002900) | 2.10898973 |
| 128 | Flat acetabular roof (HP:0003180) | 2.10756235 |
| 129 | Postural instability (HP:0002172) | 2.10613520 |
| 130 | Vertebral arch anomaly (HP:0008438) | 2.10432551 |
| 131 | Radial bowing (HP:0002986) | 2.09763284 |
| 132 | Decreased circulating renin level (HP:0003351) | 2.09712316 |
| 133 | Hypoalbuminemia (HP:0003073) | 2.07448102 |
| 134 | Abnormal albumin level (HP:0012116) | 2.07448102 |
| 135 | Abnormality of the basal ganglia (HP:0002134) | 2.07410821 |
| 136 | Tubular atrophy (HP:0000092) | 2.07357607 |
| 137 | Intrahepatic cholestasis (HP:0001406) | 2.07131500 |
| 138 | Gaze-evoked nystagmus (HP:0000640) | 2.06664391 |
| 139 | Macular degeneration (HP:0000608) | 2.03749218 |
| 140 | Abnormality of the pericardium (HP:0001697) | 2.03434775 |
| 141 | Nephronophthisis (HP:0000090) | 2.03163155 |
| 142 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.02181929 |
| 143 | Abnormal ciliary motility (HP:0012262) | 2.01451375 |
| 144 | Petechiae (HP:0000967) | 2.00356784 |
| 145 | Ectopia lentis (HP:0001083) | 2.00330107 |
| 146 | Increased mean platelet volume (HP:0011877) | 1.99490585 |
| 147 | Increased corneal curvature (HP:0100692) | 1.98860125 |
| 148 | Keratoconus (HP:0000563) | 1.98860125 |
| 149 | Cystic liver disease (HP:0006706) | 1.98793355 |
| 150 | Abnormal glucose tolerance (HP:0001952) | 1.98788835 |
| 151 | Tubulointerstitial fibrosis (HP:0005576) | 1.97293760 |
| 152 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.96910625 |
| 153 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95772677 |
| 154 | Upper motor neuron abnormality (HP:0002127) | 1.94346109 |
| 155 | Oligodontia (HP:0000677) | 1.94274080 |
| 156 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.94220958 |
| 157 | Absent/shortened dynein arms (HP:0200106) | 1.94220958 |
| 158 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.93464907 |
| 159 | Synostosis involving bones of the feet (HP:0009140) | 1.93464907 |
| 160 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91691954 |
| 161 | Attenuation of retinal blood vessels (HP:0007843) | 1.91596040 |
| 162 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91505261 |
| 163 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90448398 |
| 164 | Chronic hepatic failure (HP:0100626) | 1.89623595 |
| 165 | Abnormal platelet volume (HP:0011876) | 1.89141705 |
| 166 | Nasolacrimal duct obstruction (HP:0000579) | 1.88237860 |
| 167 | Dehydration (HP:0001944) | 1.87108583 |
| 168 | Hypoglycemic coma (HP:0001325) | 1.87077243 |
| 169 | Type I diabetes mellitus (HP:0100651) | 1.86187398 |
| 170 | Horizontal nystagmus (HP:0000666) | 1.85757517 |
| 171 | Abnormality of vitamin B metabolism (HP:0004340) | 1.85532071 |
| 172 | Renal hypoplasia (HP:0000089) | 1.85297261 |
| 173 | Ureteral obstruction (HP:0006000) | 1.84675919 |
| 174 | Onion bulb formation (HP:0003383) | 1.84410069 |
| 175 | Abnormal hemoglobin (HP:0011902) | 1.83404817 |
| 176 | Ventricular fibrillation (HP:0001663) | 1.81292085 |
| 177 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.81164849 |
| 178 | Lower limb amyotrophy (HP:0007210) | 1.81104871 |
| 179 | Hypolipoproteinemia (HP:0010981) | 1.79997759 |
| 180 | Dysmetric saccades (HP:0000641) | 1.79364337 |
| 181 | Chromsome breakage (HP:0040012) | 1.77844152 |
| 182 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77598212 |
| 183 | Abnormal ossification of hand bones (HP:0005921) | 1.77411946 |
| 184 | IgM deficiency (HP:0002850) | 1.77245098 |
| 185 | Breast aplasia (HP:0100783) | 1.77175687 |
| 186 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.75861477 |
| 187 | Purpura (HP:0000979) | 1.75196593 |
| 188 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74932916 |
| 189 | Lack of skin elasticity (HP:0100679) | 1.74472206 |
| 190 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74319990 |
| 191 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73839046 |
| 192 | Abnormal hand bone ossification (HP:0010660) | 1.73073551 |
| 193 | Abnormal protein glycosylation (HP:0012346) | 1.70141182 |
| 194 | Abnormal glycosylation (HP:0012345) | 1.70141182 |
| 195 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.70141182 |
| 196 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.70141182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 7.08418438 |
| 2 | LATS2 | 6.62828191 |
| 3 | BCR | 4.29871121 |
| 4 | TRPM7 | 3.88787629 |
| 5 | STK38L | 3.49603314 |
| 6 | MAP2K3 | 3.15762755 |
| 7 | IRAK3 | 3.06595459 |
| 8 | PRKD3 | 3.00243840 |
| 9 | MAP2K6 | 2.81740491 |
| 10 | TLK1 | 2.67444132 |
| 11 | ACVR1B | 2.51350847 |
| 12 | IRAK2 | 2.37391843 |
| 13 | FRK | 2.22716287 |
| 14 | NLK | 2.20270557 |
| 15 | STK3 | 2.10041796 |
| 16 | IRAK4 | 2.03021859 |
| 17 | LATS1 | 10.3807254 |
| 18 | MAP2K2 | 1.94624750 |
| 19 | BMPR1B | 1.91371090 |
| 20 | MELK | 1.87354009 |
| 21 | PIK3CG | 1.85524566 |
| 22 | IRAK1 | 1.83628075 |
| 23 | STK38 | 1.82532483 |
| 24 | CDK9 | 1.81058149 |
| 25 | TAOK2 | 1.73495622 |
| 26 | NME1 | 1.58779846 |
| 27 | STK16 | 1.56533116 |
| 28 | STK39 | 1.56278907 |
| 29 | CDK6 | 1.53049471 |
| 30 | PBK | 1.43439679 |
| 31 | EPHB2 | 1.42417614 |
| 32 | EPHA4 | 1.40120251 |
| 33 | PASK | 1.37879989 |
| 34 | OXSR1 | 1.37005893 |
| 35 | NUAK1 | 1.36346914 |
| 36 | MST1R | 1.35762329 |
| 37 | EPHA2 | 1.35079536 |
| 38 | HIPK2 | 1.34141783 |
| 39 | CLK1 | 1.32543921 |
| 40 | MAP3K3 | 1.21267464 |
| 41 | TGFBR2 | 1.19331993 |
| 42 | PINK1 | 1.15420791 |
| 43 | PDPK1 | 1.13206391 |
| 44 | MAP3K14 | 1.12324349 |
| 45 | PLK4 | 1.11383233 |
| 46 | EIF2AK2 | 1.10793059 |
| 47 | ERBB2 | 1.10406688 |
| 48 | MAP3K2 | 1.06040309 |
| 49 | CDK19 | 1.05261551 |
| 50 | MAPKAPK5 | 1.00917147 |
| 51 | CCNB1 | 0.99475400 |
| 52 | ERBB4 | 0.99176843 |
| 53 | NEK2 | 0.96103415 |
| 54 | KSR2 | 0.91444795 |
| 55 | RIPK4 | 0.90755203 |
| 56 | TAF1 | 0.88874562 |
| 57 | PKN1 | 0.85637685 |
| 58 | CHEK2 | 0.78507059 |
| 59 | GRK7 | 0.78244222 |
| 60 | SIK3 | 0.76819035 |
| 61 | SIK2 | 0.75133237 |
| 62 | NEK6 | 0.72560737 |
| 63 | ADRBK2 | 0.72485960 |
| 64 | ALK | 0.70400642 |
| 65 | EPHB1 | 0.69951832 |
| 66 | TGFBR1 | 0.68100852 |
| 67 | ZAK | 0.65066603 |
| 68 | JAK1 | 0.61394555 |
| 69 | PTK6 | 0.59118376 |
| 70 | ADRBK1 | 0.59086897 |
| 71 | BTK | 0.59077043 |
| 72 | INSRR | 0.58587686 |
| 73 | CDK8 | 0.58533794 |
| 74 | LMTK2 | 0.58338637 |
| 75 | CSNK1A1L | 0.57956668 |
| 76 | PRKD1 | 0.53989042 |
| 77 | CSNK1G3 | 0.53432960 |
| 78 | CDK3 | 0.53401099 |
| 79 | PLK2 | 0.53029281 |
| 80 | NTRK3 | 0.52440820 |
| 81 | NEK9 | 0.50060897 |
| 82 | TTK | 0.48609345 |
| 83 | STK4 | 0.48458251 |
| 84 | RIPK1 | 0.48093661 |
| 85 | ATR | 0.47880637 |
| 86 | FER | 0.47127877 |
| 87 | VRK1 | 0.46992061 |
| 88 | CDK4 | 0.43622470 |
| 89 | PIK3CA | 0.43127633 |
| 90 | WNK4 | 0.42622498 |
| 91 | MOS | 0.41146500 |
| 92 | GRK5 | 0.40832377 |
| 93 | PIM2 | 0.40507742 |
| 94 | MAP2K1 | 0.40432458 |
| 95 | STK11 | 0.38266225 |
| 96 | MAP2K4 | 0.37232629 |
| 97 | CDK15 | 0.37088923 |
| 98 | CDK18 | 0.36373203 |
| 99 | TNK2 | 0.35358643 |
| 100 | CSNK1G2 | 0.34734270 |
| 101 | CAMK1 | 0.34469129 |
| 102 | DAPK2 | 0.33262109 |
| 103 | EIF2AK3 | 0.32764994 |
| 104 | TIE1 | 0.32460299 |
| 105 | CAMKK1 | 0.32015982 |
| 106 | MAPK4 | 0.31899252 |
| 107 | ERBB3 | 0.31189522 |
| 108 | CSNK1G1 | 0.29307857 |
| 109 | LIMK1 | 0.28972018 |
| 110 | MKNK2 | 0.28491914 |
| 111 | AURKB | 0.28381125 |
| 112 | PRKAA2 | 0.27564770 |
| 113 | TSSK6 | 0.27523498 |
| 114 | EPHA3 | 0.27459290 |
| 115 | PRKCH | 0.26430131 |
| 116 | PLK1 | 0.25589086 |
| 117 | CDK11A | 0.25356836 |
| 118 | STK10 | 0.25231231 |
| 119 | FES | 0.25056487 |
| 120 | CSNK1D | 0.24850289 |
| 121 | PIM1 | 0.24728790 |
| 122 | CDK5 | 0.24525691 |
| 123 | PTK2B | 0.23903966 |
| 124 | PRKCE | 0.23567442 |
| 125 | PRKCQ | 0.23101492 |
| 126 | TESK2 | 0.23048820 |
| 127 | PRKG2 | 0.23028541 |
| 128 | CDK14 | 0.22810897 |
| 129 | MAP3K7 | 0.22783294 |
| 130 | CAMK1D | 0.22662993 |
| 131 | CAMK2B | 0.21015408 |
| 132 | TXK | 0.20846363 |
| 133 | SGK2 | 0.20796034 |
| 134 | MET | 0.19506114 |
| 135 | CAMK2A | 0.19076122 |
| 136 | MAPK11 | 0.19037277 |
| 137 | TNIK | 0.18824984 |
| 138 | GRK1 | 0.18247002 |
| 139 | PRKCD | 0.17953318 |
| 140 | PRKCG | 0.16387389 |
| 141 | TAOK3 | 0.15880009 |
| 142 | PDK1 | 0.15156875 |
| 143 | MAP4K2 | 0.14057427 |
| 144 | TEC | 0.09999819 |
| 145 | PRKACA | 0.09064557 |
| 146 | ABL1 | 0.08764528 |
| 147 | OBSCN | 0.08761730 |
| 148 | DDR2 | 0.08378226 |
| 149 | PRKACB | 0.08320719 |
| 150 | ITK | 0.06643062 |
| 151 | MAPK1 | 0.04734142 |
| 152 | MAPK3 | 0.04256387 |
| 153 | MYLK | 0.03731266 |
| 154 | PRKCI | 0.03297211 |
| 155 | AKT2 | 0.02074453 |
| 156 | BRD4 | 0.01433628 |
| 157 | BMPR2 | 0.01057974 |
| 158 | MATK | 0.00911885 |
| 159 | JAK2 | 0.00640538 |
| 160 | PRKG1 | 0.00603631 |
| 161 | MAP3K8 | 0.00584664 |
| 162 | NEK1 | -0.0490274 |
| 163 | RET | -0.0452855 |
| 164 | CSNK1A1 | -0.0427411 |
| 165 | AKT1 | -0.0394670 |
| 166 | GSK3B | -0.0350533 |
| 167 | PLK3 | -0.0259823 |
| 168 | PRKCB | -0.0018485 |
| 169 | MAPK8 | -0.0013417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 8.32378110 |
| 2 | Folate biosynthesis_Homo sapiens_hsa00790 | 4.84127831 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 4.09315259 |
| 4 | Malaria_Homo sapiens_hsa05144 | 3.77877700 |
| 5 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.55128840 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.38528969 |
| 7 | ABC transporters_Homo sapiens_hsa02010 | 3.26150734 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.24859832 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.16612670 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.06136612 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.89273020 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.82629474 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.52211576 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.40714294 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.39728523 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.35922517 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 2.14991181 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 2.14958100 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.12670704 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 2.00099212 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.96178886 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94866462 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90808787 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.79642264 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74485014 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73415792 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.63207795 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50897944 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50683674 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.48749375 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47393459 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.43009853 |
| 33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33556801 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30931541 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30754912 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.27219777 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26696695 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26093200 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.24675381 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24174051 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23798331 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20999411 |
| 43 | Tight junction_Homo sapiens_hsa04530 | 1.19909580 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18328724 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17189112 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13956041 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12873890 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09722982 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05540663 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01350693 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99068138 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97624703 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96618985 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96340664 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95600697 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94273872 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93990990 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88524881 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88524580 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86594372 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.85402025 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84594100 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82088946 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78856117 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.77727158 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77104589 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76324645 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75824084 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75082009 |
| 70 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74145245 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73489519 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71976788 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71464171 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70017203 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69506581 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.67953662 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67634241 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66115479 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65481998 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64996588 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64897249 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63958311 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63427159 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63365285 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63297900 |
| 86 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59027662 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.58691435 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57597989 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55890896 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55432972 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54539090 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53908790 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.53319274 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.53226714 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51186145 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50201137 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49781331 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49683666 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49202197 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49030506 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48997958 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48789939 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47463628 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46251877 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46142473 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.45446088 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45118615 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44490252 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.44343571 |
| 110 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43717510 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43556769 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43360639 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.43210538 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43060769 |
| 115 | Adherens junction_Homo sapiens_hsa04520 | 0.41434921 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41432019 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41393053 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.41011765 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.40656232 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39970646 |
| 121 | Morphine addiction_Homo sapiens_hsa05032 | 0.38858580 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38256419 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.37660123 |
| 124 | Nicotine addiction_Homo sapiens_hsa05033 | 0.36456889 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36419293 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34657770 |
| 127 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34061139 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33993302 |
| 129 | Homologous recombination_Homo sapiens_hsa03440 | 0.33126032 |
| 130 | Measles_Homo sapiens_hsa05162 | 0.32860476 |
| 131 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32638133 |
| 132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31517192 |
| 133 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30495450 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30255094 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29846145 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29631386 |
| 137 | Peroxisome_Homo sapiens_hsa04146 | 0.29043726 |
| 138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.28498130 |
| 139 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.28298113 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28169396 |
| 141 | Axon guidance_Homo sapiens_hsa04360 | 0.27950614 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27674400 |
| 143 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27458928 |
| 144 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26660716 |
| 145 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25919758 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22381383 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21307142 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19871071 |
| 149 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19170062 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18762495 |
| 151 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.18308772 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17610046 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15624865 |
| 154 | Insulin secretion_Homo sapiens_hsa04911 | 0.14701625 |
| 155 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12938887 |

